PRMT1 Is a novel regulator of epithelial-mesenchymal-transition in non-small cell lung cancer

Journal of Biological Chemistry

Volumn 290, Issue 21, 2015, Pages 13479-13489

  Avasarala, Sreedevi ^a   Van Scoyk, Michelle ^a   Rathinam, Manoj Kumar Karuppusamy ^a   Zerayesus, Sereke ^a   Zhao, Xiangmin ^a   Zhang, Wei ^b   Pergande, Melissa R ^c   Borgia, Jeffrey A ^c   DeGregori, James ^d   Port, J David ^d   Winn, Robert A ^a   Bikkavilli, Rama Kamesh ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATION; ARGININE; BIOLOGICAL ORGANS; CELL PROLIFERATION; GLYCOPROTEINS; METHYLATION; PATHOLOGY; TRANSCRIPTION;

BASIC HELIX LOOP HELIXES; CANCER CELLS; CANCER PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; LUNG CANCER; METHYLTRANSFERASES; NON SMALL CELL LUNG CANCER; NOVEL STRATEGIES;

DISEASES;

ARGININE; PROTEIN ARGININE METHYLTRANSFERASE; TRANSCRIPTION FACTOR TWIST; UVOMORULIN; CADHERIN; MESSENGER RNA; NUCLEAR PROTEIN; PRMT1 PROTEIN, HUMAN; REPRESSOR PROTEIN; SMALL INTERFERING RNA; TWIST1 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; DRUG RESEARCH; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; METASTASIS POTENTIAL; MOUSE; NON SMALL CELL LUNG CANCER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METHYLATION; PROTEIN TARGETING; UPREGULATION; AMINO ACID SEQUENCE; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL MOTION; DNA METHYLATION; DRUG SCREENING; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECONDARY; SEQUENCE HOMOLOGY; TUMOR CELL CULTURE; TUMOR INVASION; WESTERN BLOTTING; WOUND HEALING;

AMINO ACID SEQUENCE; ANIMALS; ARGININE; BLOTTING, WESTERN; CADHERINS; CARCINOMA, NON-SMALL-CELL LUNG; CELL MOVEMENT; CELL PROLIFERATION; DNA METHYLATION; EPITHELIAL-MESENCHYMAL TRANSITION; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MICE; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; NUCLEAR PROTEINS; PROTEIN-ARGININE N-METHYLTRANSFERASES; REAL-TIME POLYMERASE CHAIN REACTION; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SEQUENCE HOMOLOGY, AMINO ACID; TUMOR CELLS, CULTURED; TWIST TRANSCRIPTION FACTOR; WOUND HEALING; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84930002592     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.636050     Document Type: Article

References (47)

1. Yang, Y., and Bedford, M. T. (2013) Protein arginine methyltransferases and cancer. Nature Reviews. Cancer 13, 37-50
2. Cha, B., and Jho, E. H. (2012) Protein arginine methyltransferases (PRMTs) as therapeutic targets. Exp. Opin. Therap. Targets 16, 651-664
3. Paik, W. K., and Kim, S. (1968) Protein methylase I. Purification and properties of the enzyme. J. Biol. Chem. 243, 2108-2114
4. Lin, W. J., Gary, J. D., Yang, M. C., Clarke, S., and Herschman, H. R. (1996) The mammalian immediate-early TIS21 protein and the leukemia-associated BTG1 protein interact with a protein-arginine N-methyltransferase. J. Biol. Chem. 271, 15034-15044
5. Boffa, L. C., Karn, J., Vidali, G., and Allfrey, V. G. (1977) Distribution of NG, NG,-dimethylarginine in nuclear protein fractions. Biochem. Biophys. Res. Commun. 74, 969-976
6. Bedford, M. T. (2007) Arginine methylation at a glance. J. Cell Sci. 120, 4243-4246
7. Bedford, M. T., and Clarke, S. G. (2009) Protein arginine methylation in mammals: who, what, and why. Mol. Cell 33, 1-13
8. Bedford, M. T., and Richard, S. (2005) Arginine methylation an emerging regulator of protein function. Mol. Cell 18, 263-272
9. Lee, Y. H., and Stallcup, M. R. (2009) Minireview: protein arginine methylation of nonhistone proteins in transcriptional regulation. Mol. Endocrinol. 23, 425-433
10. Jansson, M., Durant, S. T., Cho, E. C., Sheahan, S., Edelmann, M., Kessler, B., and La Thangue, N. B. (2008) Arginine methylation regulates the p53 response. Nature Cell Biology 10, 1431-1439
11. Tadesse, H., Deschênes-Furry, J., Boisvenue, S., and Côté, J. (2008) KHtype splicing regulatory protein interacts with survival motor neuron protein and is misregulated in spinal muscular atrophy. Hum. Mol. Genet. 17, 506-524
12. Bikkavilli, R. K., and Malbon, C. C. (2011) Arginine methylation of G3BP1 in response to Wnt3a regulates {beta}-catenin mRNA. J. Cell Sci. 124, 2310-2320
13. Bikkavilli, R. K., and Malbon, C. C. (2012) Wnt3a-stimulated LRP6 phosphorylation is dependent upon arginine methylation of G3BP2. J. Cell Sci. 125, 2446-2456
14. Yamagata, K., Daitoku, H., Takahashi, Y., Namiki, K., Hisatake, K., Kako, K., Mukai, H., Kasuya, Y., and Fukamizu, A. (2008) Arginine methylation of FOXO transcription factors inhibits their phosphorylation by Akt. Mol. Cell 32, 221-231
15. Lee, J., and Bedford, M. T. (2002) PABP1 identified as an arginine methyltransferase substrate using high-density protein arrays. EMBO Rep. 3, 268-273
16. Yoshimatsu, M., Toyokawa, G., Hayami, S., Unoki, M., Tsunoda, T., Field, H. I., Kelly, J. D., Neal, D. E., Maehara, Y., Ponder, B. A., Nakamura, Y., and Hamamoto, R. (2011) Dysregulation of PRMT1 and PRMT6, Type I arginine methyltransferases, is involved in various types of human cancers. Int. J. Cancer 128, 562-573
17. Limm, K., Ott, C., Wallner, S., Mueller, D. W., Oefner, P., Hellerbrand, C., and Bosserhoff, A. K. (2013) Deregulation of protein methylation in melanoma. Eur. J. Cancer 49, 1305-1313
18. Debnath, J., Muthuswamy, S. K., and Brugge, J. S. (2003) Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in threedimensional basement membrane cultures. Methods 30, 256-268
19. Winn, R. A., Marek, L., Han, S. Y., Rodriguez, K., Rodriguez, N., Hammond, M., Van Scoyk, M., Acosta, H., Mirus, J., Barry, N., Bren-Mattison, Y., Van Raay, T. J., Nemenoff, R. A., and Heasley, L. E. (2005) Restoration of Wnt-7a expression reverses non-small cell lung cancer cellular transformation through frizzled-9-mediated growth inhibition and promotion of cell differentiation. J. Biol. Chem. 280, 19625-19634
20. Bikkavilli, R. K., Avasarala, S., Vanscoyk, M., Sechler, M., Kelley, N., Malbon, C. C., and Winn, R. A. (2012) Dishevelled3 is a novel arginine methyl transferase substrate. Scientific Reports 2, 805
21. Elakoum, R., Gauchotte, G., Oussalah, A., Wissler, M. P., Clément-Duchêne, C., Vignaud, J. M., Guéant, J. L., and Namour, F. (2014) CARM1 and PRMT1 are dysregulated in lung cancer without hierarchical features. Biochimie 97, 210-218
22. Devine, D. J., Rostas, J. W., Metge, B. J., Das, S., Mulekar, M. S., Tucker, J. A., Grizzle, W. E., Buchsbaum, D. J., Shevde, L. A., and Samant, R. S. (2014) Loss of N-Myc interactor promotes epithelial-mesenchymal transition by activation of TGFβ/SMAD signaling. Oncogene 33, 2620-2628
23. Bren-Mattison, Y., Van Putten, V., Chan, D., Winn, R., Geraci, M. W., and Nemenoff, R. A. (2005) Peroxisome proliferator-activated receptorgamma (PPAR(gamma)) inhibits tumorigenesis by reversing the undifferentiated phenotype of metastatic non-small-cell lung cancer cells (NSCLC). Oncogene 24, 1412-1422
24. Dhar, S., Vemulapalli, V., Patananan, A. N., Huang, G. L., Di Lorenzo, A., Richard, S., Comb, M. J., Guo, A., Clarke, S. G., and Bedford, M. T. (2013) Loss of the major Type I arginine methyltransferase PRMT1 causes substrate scavenging by other PRMTs. Scientific Reports 3, 1311
25. Hong, J., Zhou, J., Fu, J., He, T., Qin, J., Wang, L., Liao, L., and Xu, J. (2011) Phosphorylation of serine 68 of Twist1 by MAPKs stabilizes Twist1 protein and promotes breast cancer cell invasiveness. Cancer Res. 71, 3980-3990
26. Lander, R., Nasr, T., Ochoa, S. D., Nordin, K., Prasad, M. S., and Labonne, C. (2013) Interactions between Twist and other core epithelial-mesenchymal transition factors are controlled by GSK3-mediated phosphorylation. Nature Communications 4, 1542
27. Vichalkovski, A., Gresko, E., Hess, D., Restuccia, D. F., and Hemmings, B. A. (2010) PKB/AKT phosphorylation of the transcription factor Twist-1 at Ser42 inhibits p53 activity in response to DNA damage. Oncogene 29, 3554-3565
28. Onder, T. T., Gupta, P. B., Mani, S. A., Yang, J., Lander, E. S., and Weinberg, R. A. (2008) Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res. 68, 3645-3654
29. Yang, J., and Weinberg, R. A. (2008) Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev. Cell 14, 818-829
30. Petersen, O. W., Rønnov-Jessen, L., Howlett, A. R., and Bissell, M. J. (1992) Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. Proc. Natl. Acad. Sci. U.S.A. 89, 9064-9068
31. Shaw, K. R., Wrobel, C. N., and Brugge, J. S. (2004) Use of three-dimensional basement membrane cultures to model oncogene-induced changes in mammary epithelial morphogenesis. J. Mammary Gland Biol. Neoplasia 9, 297-310
32. Otto, E. A., Hurd, T. W., Airik, R., Chaki, M., Zhou, W., Stoetzel, C., Patil, S. B., Levy, S., Ghosh, A. K., Murga-Zamalloa, C. A., van Reeuwijk, J., Letteboer, S. J., Sang, L., Giles, R. H., Liu, Q., Coene, K. L., Estrada-Cuzcano, A., Collin, R. W., McLaughlin, H. M., Held, S., Kasanuki, J. M., Ramaswami, G., Conte, J., Lopez, I., Washburn, J., Macdonald, J., Hu, J., Yamashita, Y., Maher, E. R., Guay-Woodford, L. M., Neumann, H. P., Obermüller, N., Koenekoop, R. K., Bergmann, C., Bei, X., Lewis, R. A., Katsanis, N., Lopeüs, V., Williams, D. S., Lyons, R. H., Dang, C. V., Brito, D. A., Dias, M. B., Zhang, X., Cavalcoli, J. D., Nürnberg, G., Nürnberg, P., Pierce, E. A., Jackson, P. K., Antignac, C., Saunier, S., Roepman, R., Dollfus, H., Khanna, H., and Hildebrandt, F. (2010) Candidate exome capture identifies mutation of SDCCAG8 as the cause of a retinal-renal ciliopathy. Nat. Genet. 42, 840-850
33. Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A., and Weinberg, R. A. (2004) Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117, 927-939
34. Vesuna, F., van Diest, P., Chen, J. H., and Raman, V. (2008) Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer. Biochem. Biophys. Res. Commun. 367, 235-241
35. de Freitas Silva, B. S., Yamamoto-Silva, F. P., Pontes, H. A., and Pinto Junior, D. D. (2014) E-cadherin downregulation and Twist overexpression since early stages of oral carcinogenesis. J. Oral Pathol. Med. 43, 125-131
36. Feng, Z., Gan, H., Cai, Z., Li, N., Yang, Z., Lu, G., and Chen, J. (2013) Aberrant expression of hypoxia-inducible factor 1alpha, TWIST and E-cadherin is associated with aggressive tumor phenotypes in endometrioid endometrial carcinoma. Japanese journal of clinical oncology 43, 396-403
37. Wang, W. S., Yu, S. L., Yang, X. S., Chang, S. D., and Hou, J. Q. (2013) Expression and significance of twist and E-cadherin in ovarian cancer tissues. Asian Pacific Journal of Cancer Prevention: APJCP 14, 669-672
38. Puisieux, A., Valsesia-Wittmann, S., and Ansieau, S. (2006) A twist for survival and cancer progression. Br. J. Cancer 94, 13-17
39. Kwok, W. K., Ling, M. T., Lee, T. W., Lau, T. C., Zhou, C., Zhang, X., Chua, C. W., Chan, K. W., Chan, F. L., Glackin, C., Wong, Y. C., and Wang, X. (2005) Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target. Cancer Res. 65, 5153-5162
40. Kyo, S., Sakaguchi, J., Ohno, S., Mizumoto, Y., Maida, Y., Hashimoto, M., Nakamura, M., Takakura, M., Nakajima, M., Masutomi, K., and Inoue, M. (2006) High Twist expression is involved in infiltrative endometrial cancer and affects patient survival. Human Pathology 37, 431-438
41. Yuen, H. F., Chan, Y. P., Wong, M. L., Kwok, W. K., Chan, K. K., Lee, P. Y., Srivastava, G., Law, S. Y., Wong, Y. C., Wang, X., and Chan, K. W. (2007) Upregulation of Twist in oesophageal squamous cell carcinoma is associated with neoplastic transformation and distant metastasis. J. Clin. Pathol. 60, 510-514
42. Montserrat, N., Gallardo, A., Escuin, D., Catasus, L., Prat, J., Gutiérrez-Avigno, F. J., Peiró, G., Barnadas, A., and Lerma, E. (2011) Repression of E-cadherin by SNAIL, ZEB1, and TWIST in invasive ductal carcinomas of the breast: a cooperative effort? Human Pathology 42, 103-110
43. Hosono, S., Kajiyama, H., Terauchi, M., Shibata, K., Ino, K., Nawa, A., and Kikkawa, F. (2007) Expression of Twist increases the risk for recurrence and for poor survival in epithelial ovarian carcinoma patients. Br. J. Cancer 96, 314-320
44. Wilson-Rawls, J., Rhee, J. M., and Rawls, A. (2004) Paraxis is a basic helixloop-helix protein that positively regulates transcription through binding to specific E-box elements. J. Biol. Chem. 279, 37685-37692
45. Singh, S., and Gramolini, A. O. (2009) Characterization of sequences in human TWIST required for nuclear localization. BMC Cell Biol. 10, 47
46. Xu, J., Lamouille, S., and Derynck, R. (2009) TGF-β-induced epithelial to mesenchymal transition. Cell Res. 19, 156-172
47. Han, S. U., Lee, H. Y., Lee, J. H., Kim, W. H., Nam, H., Kim, H., Cho, Y. K., Kim, M. W., and Lee, K. U. (2005) Modulation of E-cadherin by hepatocyte growth factor induces aggressiveness of gastric carcinoma. Ann. Surg. 242, 676-683